期刊文献+

一种新的抗凝血酶基因突变导致遗传性抗凝血酶缺陷症 被引量:8

A novel mutation in antithrombin gene results in hereditary antithrombin deficiency
原文传递
导出
摘要 目的对 1 例遗传性抗凝血酶(AT)缺陷症患者及其家系成员 AT 活性(AT:A)、AT 抗原含量(AT:Ag)进行检测及基因分析,探讨该遗传性 AT 缺陷症发病的分子机制。方法采用发色底物法和免疫比浊法分别检测先证者及其家系成员血浆 AT:A 和 AT:Ag,提取外周血基因组 DNA,PCR法扩增 AT 基因的全部7个外显子及侧翼序列,DNA 序列分析 AT 的基因异常。结果先证者 AT:A和 AT:Ag 分别为45%和97 mg/L,为Ⅰ型 AT 缺陷症。AT 基因外显子5区第9833位核苷酸发生杂合性 T→A突变,引起 Tyr363Stop(Y363X)无义突变。其他家系成员基因测序结果显示有4人(Ⅱ2、Ⅱ6、Ⅲ7、Ⅲ14)存在该突变。结论该家系为Ⅰ型遗传性 AT 缺陷症 AT 基因外显子5区杂合性9833 T→A无义突变引起 AT 缺陷,导致静脉血栓是该遗传性 AT 缺陷症的分子致病机制。该突变在国际上尚未见报道。 Objective To investigate the antithrombin (AT) activity (AT: A ) and AT antigen (AT: Ag) level in a Chinese family with type [ antithrombin (AT) deficiency, and to explore the molecular mechanism of AT deficiency. Methods Immuno-nephelometry and chromogenic assay were used to detect the plasma level of AT: A and AT: Ag, respectively. Genomic DNA was isolated from the peripheral blood, and all the seven exons and exon-intron boundaries of AT gene were amplified by PCR and direct sequencing. Results The plasma levels of AT: A and AT: Ag of the proband were 45% and 97 mg/L, respectively, which led to a type Ⅰ AT deficiency. A heterozygous T to A mutation was found at nucleotide 9833 in exon 5 resulting in a Tyr363Stop nonsense mutation. The sequencing results from the pedigree indicated that four oth- er members also had this mutation. Conclusion This heterozygous nonsense mutation of T9833A in exon 5 resulting in venous thrombosis is a novel genetic defect of hereditary AT deficiency, which has not been described before.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2006年第9期598-601,共4页 Chinese Journal of Hematology
基金 2005年安徽省临床医学重点学科应用技术资助项目(05A018)
关键词 抗凝血酶缺陷症 遗传性 基因 突变 Antithrombin deficiency, hereditary Gene Mutation
  • 相关文献

参考文献6

二级参考文献40

  • 1Lane D A, Bayston T, Olds R J, et al. Antithrombin mutation database:2nd(1997) update[J]. Thromb Haemost, 1997,77:197.
  • 2Tokunagaa F, Shirotania H, Hara K, et al. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors[J]. FEBS Letters, 1997,412:65.
  • 3Fitton HL, Walker ID, Jones L, et al. Five antithrombin variants, four associated with thrombosis[J]. Blood Coagul Fibrinolysis, 1997,8:145.
  • 4Nagaizumi K, Inaba H, Amano K, et al. Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis[J].Int J Hematol, 2003,78:79.
  • 5Tanaka Y, Ueda K, Ozawa T, et al. Intracellular Accumulation of Antithrombin Morioka (C95R), a Novel Mutation Causing Type Ⅰ Antithrombin Deficiency[J]. J Biol Chem, 2002,277:51058.
  • 6Fitches AC, Lewandowski K, Olds RJ. Creation of an Additional Glycosylation Site as a Mechanism for Type Ⅰ Antithrombin Deficiency[J].Thromb Haemost, 2001,86:1023.
  • 7Chuwdhury V, Olds R. J, Lane D. A, et al. Identification of nine novel mutations in type Ⅰ antithrombin deficiency by heteroduplex screening[J]. BrJ Heamatol, 1993,84:656.
  • 8Takenaga M, Horinouchi K, Shirieda K, et al. A novel nonsense mutation in the antithronbin Ⅲ gene(Ser365 to stop) causing deep and mesenteric venous thromboses[J]. Thromb Haemost, 2001,85:570.
  • 9Mushunje A, Zhou A, Huntington JA, et al. Antithrombin ‘ DREUX'(Lys114Glu): a variant with complete loss of heparin affinity[J].Thromb Haemost, 2002,88:436.
  • 10Yamada H, Hoshi N, Kato EH, et al. Novel mutation(E113X) of antithrombin Ⅲ gene(AT3) in a woman with gestational recurrent thrombosis[J]. AmJ Med Genet, 2000,91:348.

共引文献34

同被引文献97

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部